Latest News and Press Releases

Announced FDA acceptance of Mydcombi New Drug Application (NDA) and PDUFA action date of May 8, 2023 Announced positive results from Microline Phase 3 program as a potential treatment for presbyopia...

REDWOOD CITY, Calif., March 30, 2023 (GLOBE NEWSWIRE) -- PROCEPT® BioRobotics Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing...

Kalamazoo, Michigan, March 30, 2023 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that it will report financial results for first quarter of fiscal year 2023 on Monday, May 1, 2023.  A press...

Quebec City, Canada, March 30, 2023 (GLOBE NEWSWIRE) -- Viridis Terra is restoring degraded and unproductive lands to bring back valuable natural resources while yielding financial returns for...

Rafael Hernández Brito, Greivis Vásquez, and Carlos Morales Call the Action Westwood One’s Audio to be Distributed by Univision Broadcasts Presented by Werner Ladder NEW YORK, March 30, 2023 ...

Continued 2+ year trend of consecutive record quarterly growth; fastest growing brand in the US breast market Disciplined cash management and enhanced operating leverage for 40% improvement in free...

MIAMI, March 30, 2023 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the “Company”), a specialty pharmaceutical company focused on the development and commercialization of...

MIDLAND, Texas, March 30, 2023 (GLOBE NEWSWIRE) -- On March 28, 2023, Michael P. Cross, who has been a member of the Board of Directors (the “Board”) of Diamondback Energy, Inc. (NASDAQ: FANG)...

`Four patients enrolled in open-label Phase 1b kidney transplant trial with clinical data on first three patients to be presented at the World Congress of Nephrology (WCN) on March 31, 2023 Safety...

Q4 2022 DANYELZA® record net product revenues of $16.4 million, driving YoY growth of 71% and 31% sequential increase compared to Q3 2022DANYELZA conditional marketing authorization granted in China...